Bioprocess Hub
Join free
← All articles
Bioprocessing & Pharma

Lundbeck continues neuroscience evolution as CEO keeps company ‘punching above its weight’

By Fraiser Kansteiner · 8/21/2026

Almost three years into his tenure as Lundbeck’s CEO, Charl van Zyl is confident the company can prove its mettle as a “neuroscience challenger” capable of “punching above its weight.”

This is a preview. Read the complete article on Fierce Pharma.

Read the full article →